Mei Han

Title: Innovations by Inventor Mei Han

Introduction

Mei Han is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of immunology, particularly in the expansion of double negative T cells. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

One of Mei Han's latest patents is a method of expanding double negative T cells in culture. This method involves several steps: providing a starting sample comprising DN T cells or their precursors, substantially depleting CD8 and CD4 T cells from the sample, and culturing the sample with an immobilized T cell mitogen in a growth-stimulating culture medium. The process continues with washing the cells and resuspending them in a culture medium without the T cell mitogen, followed by another wash and resuspension in a medium containing both the agent and a soluble T cell mitogen. The DN T cells obtained through this method are useful in treating cancer, infectious diseases, graft versus host disease, and autoimmune diseases.

Career Highlights

Mei Han is affiliated with the University Health Network, where he conducts his research and develops his innovative methods. His work is recognized for its potential to advance therapeutic strategies in immunology.

Collaborations

Some of Mei Han's coworkers include Pouneh Dokouhaki and Li Zhang, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Mei Han's innovative methods in expanding double negative T cells represent a significant advancement in immunological research. His contributions have the potential to lead to new treatments for various diseases, showcasing the importance of innovation in the medical field.